Navigation Links
SynapDx Corporation Raises $9 Million in Series A Funding
Date:6/1/2010

WALTHAM, Mass., June 1 /PRNewswire/ -- SynapDx Corp., a new company focused on developing and commercializing diagnostic testing for the early detection of autism, announced the completion of a $9 million Series A financing by Bain Capital Ventures, General Catalyst Partners, and North Bridge Venture Partners.

"Autism has a profound effect on children and their families," said Stanley N. Lapidus, the company's founder, President and Chief Executive Officer.  "The right objective blood-based diagnostic test for autism may help achieve earlier diagnosis, more rapid intervention, and improved outcomes."

About SynapDx Corp.

SynapDx was formed to develop and commercialize blood-based diagnostic tests for the early detection of autism.  SynapDx was founded by Stanley N. Lapidus, an experienced life-sciences entrepreneur and inventor with 31 issued patents.  Mr. Lapidus founded and led Cytyc Corp., EXACT Sciences Corp., and Helicos BioSciences Corp.  Mr. Lapidus' co-founders of SynapDx Corp. include Jeffrey R. Luber, Esq. and Patrick A. Anquetil, PhD.

www.synapdx.com


'/>"/>
SOURCE SynapDx Corp.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1

Related medicine technology :

1. Cardiogenesis Corporation to Present at Noble Financial - ONTRACK 2010
2. Centene Corporation to Present at Two Upcoming Healthcare Conferences in June
3. West Physics Consulting Signs Exclusive Arrangement With Digirad Corporation
4. AndroScience Corporation Forms Strategic Alliance With Taiwan Based Orient Europharma to Develop Novel Topical Acne Therapeutic
5. Thoratec Announces Early Termination of HSR Waiting Period for the Sale of ITC to Danaher Corporation
6. Oxford Finance Corporation Facilitates Entry for Reata Pharmaceuticals into Asian Markets
7. Somanetics Corporation Announces 24 Clinical Abstracts on INVOS System Presented at Annual Pediatric Academic Societies National Conference
8. Curexo Technology Corporation Raises $13.2 Million
9. Waters Corporation and NIBRT Partner to Bring Greater Control and Predictability to Biopharmaceutical Processing
10. Volcano Corporation Presentation at Bank of America Merrill Lynch Health Care Conference to Be Webcast
11. DURECT Corporation Invites You to Join Its First Quarter 2010 Earnings Conference Call
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/24/2017)... UNION CITY, Calif. , April 24, 2017 /PRNewswire/ ... providing durability, grip, protection, and comfort, announces the release ... the Powerform S8+. This most recent example of leading ... high density grip pattern for 200% more tactile grip ... in user protection and durability. With TracTek and a ...
(Date:4/21/2017)... -- Halo Labs announces the launch of a novel ... the Horizon at PEGS 2017 in Boston ... sub visible particulate matter in biopharmaceutical samples to enable ... as candidate selection and pre-formulation. Halo Labs ... Elion Labs for system validation. "We are ...
(Date:4/20/2017)... -- Vivify Health, the pioneer and market leader of remote ... significant patent for the advancement of healthcare delivery from ... health.  This landmark patent provides the company with broad ... position as the leader in remote care.  ... to apply consumer mobile devices, wireless biometrics, EMR integration ...
Breaking Medicine Technology:
(Date:4/26/2017)... (PRWEB) , ... April 26, 2017 , ... ... Women's Excellence specializes in pelvic conditions and has helped many women become ... Excellence uses a combination of office-based and simple outpatient evaluations. We can ...
(Date:4/26/2017)... ... ... RawTrition now brings you BioEnergy which is a powder capsule whole food ... RawTrition is taking nutrients to the next level! The superfoods in RawTrition's BioEnergy ... (unlike the synthetically made options that are on the market). , Founder of RawTrition, ...
(Date:4/26/2017)... ... 2017 , ... New SUPRO® XT55 Isolated Soy Protein ... helping beverage manufacturers more effectively manage protein costs. “Soy protein has always been ... as more stable pricing over time. Now it’s even more relevant as plant ...
(Date:4/26/2017)... ... 2017 , ... MYOLYN, a medical technology company dedicated to ... 510(k) clearance from the U.S. Food & Drug Administration (FDA) for two of ... are stationary cycling systems that use MYOLYN’s patent-pending functional electrical stimulation (FES) ...
(Date:4/25/2017)... , ... April 25, 2017 , ... ... and collaboration, announces Mirroring360 Pro . This new addition to the Mirroring360 ... experience for education and business. , Mirroring360 Pro enables educators, business professionals and ...
Breaking Medicine News(10 mins):